You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Omega-3-carboxylic acids - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for omega-3-carboxylic acids and what is the scope of freedom to operate?

Omega-3-carboxylic acids is the generic ingredient in one branded drug marketed by Astrazeneca and is included in one NDA. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Omega-3-carboxylic acids has eighty-four patent family members in forty countries.

There is one drug master file entry for omega-3-carboxylic acids.

Summary for omega-3-carboxylic acids
International Patents:84
US Patents:7
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 1
Raw Ingredient (Bulk) Api Vendors: 71
Clinical Trials: 34
DailyMed Link:omega-3-carboxylic acids at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for omega-3-carboxylic acids
Generic Entry Date for omega-3-carboxylic acids*:
Constraining patent/regulatory exclusivity:
Dosage:
CAPSULE;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for omega-3-carboxylic acids

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mabaret Al-Asafara HospitalsPhase 4
Assiut UniversityPhase 4
Al-Azhar UniversityPhase 1

See all omega-3-carboxylic acids clinical trials

US Patents and Regulatory Information for omega-3-carboxylic acids

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca EPANOVA omega-3-carboxylic acids CAPSULE;ORAL 205060-001 May 5, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Astrazeneca EPANOVA omega-3-carboxylic acids CAPSULE;ORAL 205060-001 May 5, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Astrazeneca EPANOVA omega-3-carboxylic acids CAPSULE;ORAL 205060-001 May 5, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Astrazeneca EPANOVA omega-3-carboxylic acids CAPSULE;ORAL 205060-001 May 5, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Astrazeneca EPANOVA omega-3-carboxylic acids CAPSULE;ORAL 205060-001 May 5, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Astrazeneca EPANOVA omega-3-carboxylic acids CAPSULE;ORAL 205060-001 May 5, 2014 DISCN Yes No ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for omega-3-carboxylic acids

Country Patent Number Title Estimated Expiration
Israel 177462 כפסול ג'לטין רך המכיל חומצה שמנית אומגה-3-רב-לא-רוויה (Soft gelatin capsule comprising omega-3-polyunsaturated fatty acid) ⤷  Sign Up
Germany 602005019402 ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2016175868 ⤷  Sign Up
Colombia 7061070 Composiciones enriquecidas con dpa de ácidos grasos omega 3 poliinsaturados en forma de ácido libre ⤷  Sign Up
Peru 20142459 COMPOSICIONES ENRIQUECIDAS CON DPA DE ACIDOS GRASOS OMEGA 3 POLIINSATURADOS EN FORMA DE ACIDO LIBRE ⤷  Sign Up
South Korea 20140135695 DPA-ENRICHED COMPOSITIONS OF OMEGA-3 POLYUNSATURATED FATTY ACIDS IN FREE ACID FORM ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.